Arazlo
- Product NDC
- 0187-2098
- 11-digit product format
- 001872098
- Labeler code
- 0187
- Product ID
- 0187-2098_06456968-fe83-2c27-e063-6294a90af3ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tazarotene
- Dosage form
- LOTION
- Route
- TOPICAL
- Labeler
- Bausch Health US, LLC
- Application
- NDA211882
- Marketing category
- NDA
- Marketing start
- 2019-12-19
- Substance
- TAZAROTENE
- Active strength
- .45 mg/g
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Arazlo
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TAZAROTENE | .45 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 81BDR9Y8PS |
| Rxcui | 2267561, 2267566 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0187-2098 | ARAZLO (TAZAROTENE) LOTION [BAUSCH HEALTH US, LLC] | 5 | Current NDC, Legacy NDC, 4 package rows | 20230927_d941ff25-c221-4a55-8012-0dcf3bbcbbd1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0187-2098-03 | 00187209803 | 3 g in 1 TUBE | 3 g | | | | | Historical |
| 0187-2098-10 | 00187209810 | 10 TUBE in 1 CARTON (0187-2098-10) / 3 g in 1 TUBE (0187-2098-03) | 10 tube | 2019-12-19 | 0000-00-00 | Yes | No | Current |
| 0187-2098-45 | 00187209845 | 1 TUBE in 1 CARTON (0187-2098-45) / 45 g in 1 TUBE | 1 tube | 2019-12-19 | 0000-00-00 | No | No | Current |